Patent ID: 11891420
Assignee: LARIMAR THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 0:
1. A fusion protein, comprising:
a protein of interest to be delivered to a cell;
a cell penetrating peptide (CPP); and
a target enhancing sequence (TES);
wherein the fusion protein comprises:
an amino acid sequence having at least 85% sequence identity to SEQ ID NO: 55;
an amino acid sequence having at least 85% sequence identity to SEQ ID NO: 56;
an amino acid sequence having at least 85% sequence identity to SEQ ID NO: 81;
an amino acid sequence having at least 96% sequence identity to SEQ ID NOs: 58;
an amino acid sequence having at least 97% sequence identity to SEQ ID NOs: 60;
an amino acid sequence having at least 97% sequence identity to SEQ ID NO: 61;
an amino acid sequence having at least 98% sequence identity to SEQ ID NO: 57; or
an amino acid sequence having at least 98% sequence identity to SEQ ID NO: 59.